Bicycle Therapeutics (BCYC) Other Operating Expenses (2018 - 2026)
Bicycle Therapeutics (BCYC) posted Other Operating Expenses of -$2.5 million for Q1 2026, up 1.82% on a QoQ basis from -$2.6 million in Q4 2025, and down 15.69% year-over-year from -$3.0 million in Q1 2025.
Bicycle Therapeutics (BCYC) Other Operating Expenses (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' Other Operating Expenses history runs 5 years deep, the most recent figure standing at -$2.5 million for Q1 2026.
- Quarterly Other Operating Expenses fell 15.69% year-over-year to -$2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.9 million (down 7.56% YoY) and the FY2025 annual result came in at -$9.6 million, down 5.86% from the prior year.
- Other Operating Expenses was -$2.5 million for Q1 2026 at Bicycle Therapeutics, up from -$2.6 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at -$1.9 million in Q2 2024 and bottomed at -$2.6 million in Q4 2024.
- A 3-year average of -$2.4 million and a median of -$2.5 million in 2025 frame the typical range for Other Operating Expenses.
- Peak annual rise in Other Operating Expenses reached 2.29% in 2025, while the deepest fall reached 21.45% in 2025.
- Bicycle Therapeutics' Other Operating Expenses stood at -$2.6 million in 2024, then changed by 0.0% to -$2.6 million in 2025, then grew by 1.82% to -$2.5 million in 2026.
- Business Quant data shows BCYC's Other Operating Expenses at -$2.5 million in Q1 2026, -$2.6 million in Q4 2025, and -$2.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Bicycle Therapeutics | 272.11 Mn | 272.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.54 Mn |
| Dec 31, 2025 | -2.58 Mn |
| Sep 30, 2025 | -2.47 Mn |
| Jun 30, 2025 | -2.33 Mn |
| Mar 31, 2025 | -2.19 Mn |
| Dec 31, 2024 | -2.58 Mn |
| Sep 30, 2024 | -2.53 Mn |
| Jun 30, 2024 | -1.92 Mn |
| Mar 31, 2024 | -2.02 Mn |
| Dec 31, 2020 | -1,000.00 |
| Mar 31, 2018 | 5.70 Mn |